Eliem Therapeutics, Inc.
NASDAQ:ELYM
5.11 (USD) • At close October 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -35.119 | -45.244 | -47.48 | -20.668 | -6.547 |
| Depreciation & Amortization
| 0 | 0 | 1.845 | 0 | 0 |
| Deferred Income Tax
| 0 | -1.39 | -1.845 | 0 | 0 |
| Stock Based Compensation
| 12.806 | 6.991 | 3.737 | 0.707 | 0 |
| Change In Working Capital
| 3.764 | 0.21 | -4.172 | -2.936 | -0.309 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.686 | -0.653 | 0.15 | -0.024 | 0.017 |
| Other Working Capital
| 4.45 | 0.863 | -4.322 | -2.912 | -0.326 |
| Other Non Cash Items
| -2.05 | 2.064 | 11.843 | 8.799 | 1.848 |
| Operating Cash Flow
| -20.599 | -37.369 | -36.072 | -14.098 | -5.008 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0.008 | 0 |
| Purchases Of Investments
| -58.449 | -87.963 | -114.97 | 0 | 0 |
| Sales Maturities Of Investments
| 127.43 | 122.403 | 0 | 0 | 0 |
| Other Investing Activites
| 0.069 | 0.034 | -0.115 | 8.07 | 0 |
| Investing Cash Flow
| 68.981 | 34.44 | -114.97 | 8.078 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.841 | 0 | 83.144 | 4.925 | 26.243 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.841 | 0 | 94.088 | 4.925 | 26.243 |
| Financing Cash Flow
| 0.841 | 0 | 177.232 | 4.925 | 26.243 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0.304 | -0.408 | 0.245 | 0.359 | -0.012 |
| Net Change In Cash
| 49.527 | -3.337 | 26.435 | -0.736 | 21.223 |
| Cash At End Of Period
| 93.112 | 43.585 | 46.922 | 20.487 | 21.223 |